CYP19A1 and breast carcinoma: Elevated levels of aromatase expression have been observed in breast tumors relative to normal breast tissue [3], and alterations in aromatase expression have been implicated in the pathogenesis of estrogen-dependent diseases, including breast cancer (BC) [4,5].